About:
This 1.0-hour foundational webinar is designed to provide clinical and non-clinical healthcare professionals working in HIV/AIDS prevention and care with essential knowledge about the relationship between HIV and viral hepatitis. Participants will receive a comprehensive overview of current epidemiological trends, as well as best-practice strategies for screening, testing, treatment, and prevention for individuals with and without an HIV diagnosis who may be affected by viral hepatitis.
Speaker:
Toan Ha, MD, DrPH
Assistant Professor, Department of Infectious Diseases & Microbiology
Assistant Director | Lead Evaluator, MidAtlantic AETC
University of Pittsburgh, School of Public Health
Learning Objectives:
By the end of this session, the learner will be able to:
1. Identify key transmission routes and epidemiology of HIV, Hepatitis B (HBV), and Hepatitis C (HCV) in the United States (US).
2. Recognize the clinical impact of HBV and HCV coinfection among people with HIV.
3. Apply recommended screening and prevention strategies for HIV, HBV, and HCV.
4. Describe integrated clinical approaches to management and prevention.
Acknowledgement:
This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) with 0% financed with non-governmental sources. The contents in this presentation are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.
